Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Clinical scores | |||||
[30]
RCT Crossover design 3-armed trial |
16 people |
Clinical score and self-evaluation of tremor
5 weeks
with primidone with placebo |
P <0.05 |
Effect size not calculated | primidone |
[32]
RCT Crossover design |
22 people |
Clinical score (hand tremor)
10 weeks
with primidone with placebo |
P <0.02 |
Effect size not calculated | primidone |
Self-rating | |||||
[32]
RCT Crossover design |
22 people |
Self-evaluation (hand tremor)
10 weeks
with primidone with placebo |
P <0.01 |
Effect size not calculated | primidone |
Performance tests | |||||
[8]
RCT Crossover design 4-armed trial |
22 people |
Observer-rated score based on ability to write, feed, and function socially
4 weeks
5.2 with primidone 7.8 with placebo |
Significance of the difference between primidone and placebo not assessed |
||
[32]
RCT Crossover design |
22 people |
Functional tests (hand tremor)
10 weeks
with primidone with placebo |
P <0.01 |
Effect size not calculated | primidone |